Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR9 | P51686 | 17/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | CCR2 | P41597 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL343980 | 0.88 | CCR9 (0.59) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL14074075 | 0.88 | CCR9 (0.62) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL343349 | 0.87 | CCR9 (0.69) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL14064704 | 0.86 | CCR9 (0.60) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL343000 | 0.84 | CCR9 (0.58) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL4882414 | 0.84 | CCR9 (0.58) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL16574549 | 0.79 | LMNA (0.65) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL342201 | 0.79 | CCR9 (0.75) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL344365 | 0.79 | CCR9 (0.57) | CCR9LMNAHTTTP53MAPT | |
| SCHEMBL344936 | 0.77 | CCR9 (0.86) | CCR9LMNAHTTTP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7420055-B2 | Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide | CHEMOCENTRYX, INC. (US) | 2008-09-02 | — | — | US | disclosed |
| US-7420055-B2 | Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide | CHEMOCENTRYX, INC. (US) | 2008-09-02 | — | — | US | disclosed |